• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Update on MRI of Cystic Renal Masses Including Bosniak Version 2019.囊性肾肿物 MRI 评估更新包括 Bosniak 2019 版
J Magn Reson Imaging. 2021 Aug;54(2):341-356. doi: 10.1002/jmri.27364. Epub 2020 Oct 2.
2
Evaluation of class II cystic renal masses proposed in Bosniak classification version 2019: a systematic review of supporting evidence.2019 年 Bosniak 分类版本中提出的 II 类囊性肾肿块的评估:支持证据的系统评价。
Abdom Radiol (NY). 2021 Oct;46(10):4888-4897. doi: 10.1007/s00261-021-03180-y. Epub 2021 Jun 21.
3
Bosniak Classification of Cystic Renal Masses Version 2019: Comparison of Categorization Using CT and MRI.2019 年版囊性肾脏肿物 Bosniak 分类:CT 和 MRI 分类的比较。
AJR Am J Roentgenol. 2021 Feb;216(2):412-420. doi: 10.2214/AJR.20.23656. Epub 2020 Dec 23.
4
Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses.2019版Bosniak II级和IIF级T1高信号囊性肾肿块的恶性风险
Abdom Radiol (NY). 2023 Aug;48(8):2636-2648. doi: 10.1007/s00261-023-03955-5. Epub 2023 May 18.
5
Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management.囊性肾肿块的影像学表现与组织病理学相关性的当代更新,并重点介绍患者管理。
Clin Radiol. 2019 Feb;74(2):83-94. doi: 10.1016/j.crad.2018.09.003. Epub 2018 Oct 9.
6
Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use.Bosniak 分类法在囊性肾脏肿块中的应用(2019 年版):临床应用的影像学指南。
Radiographics. 2021 May-Jun;41(3):814-828. doi: 10.1148/rg.2021200160. Epub 2021 Apr 16.
7
Bosniak Classification Version 2019 of Cystic Renal Masses Assessed With MRI.2019 年 Bosniak 分类法评估囊性肾脏肿块的 MRI。
AJR Am J Roentgenol. 2020 Aug;215(2):413-419. doi: 10.2214/AJR.19.22740. Epub 2020 Jun 9.
8
Proportion of malignancy in Bosniak classification of cystic renal masses version 2019 (v2019) classes: systematic review and meta-analysis.2019年版(v2019)囊性肾肿块博斯尼亚克分类中恶性肿瘤的比例:系统评价和荟萃分析。
Eur Radiol. 2023 Feb;33(2):1307-1317. doi: 10.1007/s00330-022-09102-w. Epub 2022 Aug 24.
9
Comparison of Bosniak Classification of cystic renal masses version 2019 assessed by CT and MRI.CT和MRI评估的2019版囊性肾肿块的博斯尼亚克分类比较
Abdom Radiol (NY). 2021 Nov;46(11):5268-5276. doi: 10.1007/s00261-021-03236-z. Epub 2021 Aug 14.
10
Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment.Bosniak 分类法在囊性肾脏肿块中的应用(2019 年版):更新建议与需求评估。
Radiology. 2019 Aug;292(2):475-488. doi: 10.1148/radiol.2019182646. Epub 2019 Jun 18.

引用本文的文献

1
Theranostic Nanoprobes Assisted NIR-II Fluorescence Imaging for Efficient Angiography and Tumor Therapy.用于高效血管造影和肿瘤治疗的诊疗纳米探针辅助近红外二区荧光成像
ACS Omega. 2025 May 15;10(20):20674-20685. doi: 10.1021/acsomega.5c01553. eCollection 2025 May 27.
2
Insights into Radiology Publications.放射学出版物洞察
Indian J Radiol Imaging. 2025 Jan 9;35(Suppl 1):S18-S29. doi: 10.1055/s-0044-1793914. eCollection 2025 Jan.
3
Clinical value of contrast-enhanced ultrasound combined with quantitative analysis in Bosniak ≥ II cystic renal masses.超声造影联合定量分析在Bosniak≥II级囊性肾肿块中的临床价值
Abdom Radiol (NY). 2024 Dec 18. doi: 10.1007/s00261-024-04744-4.
4
Sclerotherapy of a Symptomatic Renal Cyst.有症状肾囊肿的硬化治疗
Turk Arch Pediatr. 2024 May 2;59(3):318-320. doi: 10.5152/TurkArchPediatr.2024.24033.
5
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal.囊性透明细胞肾细胞癌:形态学与分子学再评估
Cancers (Basel). 2023 Jun 26;15(13):3352. doi: 10.3390/cancers15133352.
6
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.2023年更新——加拿大泌尿外科协会指南:囊性肾病变的管理 在最初发布(2017年3月)之前,本指南经过了加拿大泌尿外科协会指南委员会、广大加拿大泌尿外科协会成员以及加拿大泌尿外科协会执行委员会的审查。2023年的更新内容已获加拿大泌尿外科协会指南委员会和加拿大泌尿外科协会执行委员会批准。
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
7
Satisfaction of search awareness in trauma radiology: Malignant renal lesion on a trauma thoracolumbar spine CT.
Radiol Case Rep. 2023 May 12;18(7):2474-2477. doi: 10.1016/j.radcr.2023.04.004. eCollection 2023 Jul.
8
Deep learning and radiomic feature-based blending ensemble classifier for malignancy risk prediction in cystic renal lesions.基于深度学习和影像组学特征的融合集成分类器用于囊性肾病变恶性风险预测
Insights Imaging. 2023 Jan 11;14(1):6. doi: 10.1186/s13244-022-01349-7.
9
Stratification of malignant renal neoplasms from cystic renal lesions using deep learning and radiomics features based on a stacking ensemble CT machine learning algorithm.基于堆叠集成CT机器学习算法,利用深度学习和影像组学特征对囊性肾病变中的恶性肾肿瘤进行分层。
Front Oncol. 2022 Oct 25;12:1028577. doi: 10.3389/fonc.2022.1028577. eCollection 2022.
10
Accuracy of MRI without intracavernosal prostaglandin E1 injection in staging, preoperative evaluation, and operative planning of penile cancer.MRI 检查在阴茎癌分期、术前评估和手术计划中的准确性,无需注射前列腺素 E1 。
Abdom Radiol (NY). 2021 Oct;46(10):4984-4994. doi: 10.1007/s00261-021-03194-6. Epub 2021 Jun 29.

本文引用的文献

1
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.接受 II 类钆基造影剂的 4 或 5 期慢性肾脏病患者发生肾源性系统纤维化的风险:系统评价和荟萃分析。
JAMA Intern Med. 2020 Feb 1;180(2):223-230. doi: 10.1001/jamainternmed.2019.5284.
2
Are Hemorrhagic Cysts Hyperintense Enough on T1-Weighted MRI to Be Distinguished From Renal Cell Carcinomas? A Retrospective Analysis of 204 Patients.基于 T1 加权 MRI 的信号强度,出血性囊肿是否足以与肾细胞癌相鉴别?204 例患者的回顾性分析。
AJR Am J Roentgenol. 2019 Dec;213(6):1267-1273. doi: 10.2214/AJR.19.21257. Epub 2019 Sep 18.
3
Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists.加拿大放射学家协会发布的更新版《肾脏疾病中钆类造影剂使用的临床实践指南》。
Can Assoc Radiol J. 2019 Aug;70(3):226-232. doi: 10.1016/j.carj.2019.04.001. Epub 2019 Jun 27.
4
Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment.Bosniak 分类法在囊性肾脏肿块中的应用(2019 年版):更新建议与需求评估。
Radiology. 2019 Aug;292(2):475-488. doi: 10.1148/radiol.2019182646. Epub 2019 Jun 18.
5
Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses.快速千伏切换双能 CT 衰减差和碘浓度阈值对检测肾肿块增强的诊断准确性。
AJR Am J Roentgenol. 2019 Sep;213(3):619-625. doi: 10.2214/AJR.18.20990. Epub 2019 May 23.
6
Update on Gadolinium-Based Contrast Agent-Enhanced Imaging in the Genitourinary System.钆基造影剂增强成像在泌尿系统中的最新进展
AJR Am J Roentgenol. 2019 Jun;212(6):1223-1233. doi: 10.2214/AJR.19.21137. Epub 2019 Apr 11.
7
Update on Indications for Percutaneous Renal Mass Biopsy in the Era of Advanced CT and MRI.先进CT和MRI时代经皮肾肿物活检指征的最新进展
AJR Am J Roentgenol. 2019 Jun;212(6):1187-1196. doi: 10.2214/AJR.19.21093. Epub 2019 Mar 27.
8
Active Surveillance of Small (< 4 cm) Bosniak Category 2F, 3, and 4 Renal Lesions: What Happens on Imaging Follow-Up?对小型(<4厘米)博斯尼亚克2F、3和4类肾病变的主动监测:影像学随访结果如何?
AJR Am J Roentgenol. 2019 Jun;212(6):1215-1222. doi: 10.2214/AJR.18.20758. Epub 2019 Mar 12.
9
Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis.主动监测与肾部分切除术治疗 Bosniak IIF 或 III 型肾囊肿:成本效益分析。
AJR Am J Roentgenol. 2019 Apr;212(4):830-838. doi: 10.2214/AJR.18.20415. Epub 2019 Feb 19.
10
Predicting aggressive behavior in small renal tumors prior to treatment.治疗前预测小肾肿瘤的侵袭性行为。
Ann Transl Med. 2018 Dec;6(Suppl 2):S132. doi: 10.21037/atm.2018.12.46.

囊性肾肿物 MRI 评估更新包括 Bosniak 2019 版

Update on MRI of Cystic Renal Masses Including Bosniak Version 2019.

机构信息

Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

J Magn Reson Imaging. 2021 Aug;54(2):341-356. doi: 10.1002/jmri.27364. Epub 2020 Oct 2.

DOI:10.1002/jmri.27364
PMID:33009722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017011/
Abstract

Incidental cystic renal masses are common, usually benign, and almost always indolent. Since 1986, the Bosniak classification has been used to express the risk of malignancy in a cystic renal mass detected at imaging. Historically, magnetic resonance imaging (MRI) was not included in that classification. The proposed Bosniak v.2019 update has formally incorporated MRI, included definitions of imaging terms designed to improve interobserver agreement and specificity for malignancy, and incorporated a variety of masses that were incompletely defined or not included in the original classification. For example, at unenhanced MRI, homogeneous masses markedly hyperintense at T -weighted imaging (similar to cerebrospinal fluid) and homogeneous masses markedly hyperintense at fat suppressed T -weighted imaging (approximately ≥2.5 times more intense than adjacent renal parenchyma) are classified as Bosniak II and may be safely ignored, even when they have not been imaged with a complete renal mass MRI protocol. MRI has specific advantages and is recommended to evaluate masses that at computed tomography (CT) 1) have abundant thick or nodular calcifications; 2) are homogeneous, hyperattenuating, ≥3 cm, and nonenhancing; or 3) are heterogeneous and nonenhancing. Although MRI is generally excellent for characterizing cystic renal masses, there are unique weaknesses of MRI that bear consideration. These details and others related to MRI of cystic renal masses are described in this review, with an emphasis on Bosniak v.2019. A website (https://bosniak-calculator.herokuapp.com/) and mobile phone apps named "Bosniak Calculator" have been developed for ease of assignment of Bosniak classes. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY STAGE: 3.

摘要

偶然发现的囊性肾肿块很常见,通常为良性,且几乎总是惰性的。自 1986 年以来,Bosniak 分类法已被用于表达在影像学检查中发现的囊性肾肿块的恶性风险。从历史上看,磁共振成像(MRI)并不包括在该分类中。拟议的 Bosniak v.2019 更新正式纳入了 MRI,包括旨在提高观察者间一致性和恶性肿瘤特异性的影像学术语定义,并纳入了各种在原始分类中未完全定义或未包括的肿块。例如,在未增强的 MRI 上,T1 加权成像(类似于脑脊液)明显高信号的均匀性肿块和脂肪抑制 T1 加权成像(与相邻肾实质相比,大约高 2.5 倍以上)明显高信号的均匀性肿块被归类为 Bosniak II 级,可以安全忽略,即使它们没有使用完整的肾肿块 MRI 方案进行成像。MRI 具有特定的优势,推荐用于评估以下 CT 表现的肿块:1)有丰富的厚或结节状钙化;2)为均匀性、高衰减、≥3cm 且无强化;或 3)为异质性且无强化。尽管 MRI 通常非常适合于囊性肾肿块的特征描述,但 MRI 也有其独特的局限性,需要考虑。本文对囊性肾肿块的 MRI 进行了描述,重点介绍了 Bosniak v.2019。还开发了一个名为“Bosniak 计算器”的网站(https://bosniak-calculator.herokuapp.com/)和手机应用程序,用于方便 Bosniak 分级的分配。证据水平:5 技术功效分期:3。